Kenichiro Suwa1, Ozair Abdul Rahman1, Emilie Bollache1, Michael J Rose2, Amir Ali Rahsepar1,3, James C Carr1, Jeremy D Collins1, Alex J Barker1, Michael Markl1,4. 1. Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 2. Department of Medical Imaging, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. 3. Department of Radiology, Yale New Haven Health System, Bridgeport Hospital, Bridgeport, Connecticut, USA. 4. Department of Biomedical Engineering, Northwestern University McCormick School of Engineering, Chicago, Illinois, USA.
Abstract
BACKGROUND: The effect of different expressions of aortic valve disease on 3D aortic hemodynamics is unclear. PURPOSE: To investigate changes in aortic hemodynamics in patients with dilated ascending aorta (AAo) but different severity of aortic valve stenosis (AS) and/or regurgitation (AR). STUDY TYPE: Retrospective. POPULATION: A total of 111 subjects (86 patients with AAo diameter ≥ 40 mm and 25 healthy controls, all with trileaflet aortic valve [TAV]). Patients were further stratified by TAV dysfunction: n = 9 with combined moderate or severe AS and AR (ASR, 56 ± 13 years), n = 14 with moderate or severe AS (AS, 64 ± 14 years), n = 33 with moderate or severe AR (AR, 62 ± 14 years), n = 30 with neither AS nor AR (no AS/AR, 63 ± 9 years). FIELD STRENGTH/SEQUENCE: 4D flow MRI on 1.5/3T systems for the in vivo analysis of aortic blood flow dynamics. ASSESSMENT: Data analysis included grading of 3D AAo vortex/helix flow and AAo flow eccentricity as well as quantification of systolic peak velocities and wall shear stress (WSS). STATISTICAL TESTS: Continuous variables were compared by one-way analysis of variance or Kruskal-Wallis, followed by a pairwise Tukey or Dunn test if there was a significant difference. RESULTS: All patients demonstrated markedly elevated vortex and helix flow compared with controls (P < 0.05). Peak velocities were significantly elevated in ASR, AS, and AR patients compared with controls (P < 0.05). Increased flow eccentricity was observed in entire AAo for AR, at the mid and distal AAo for ASR and AS, and at the proximal AAo for no AS/AR. Compared with controls, WSS in the AAo was significantly elevated in ASR and AS patients (P < 0.05) and reduced in no AS/AR patients (P < 0.05). DATA CONCLUSION: The presence of TAV dysfunction is associated with aberrant hemodynamics and altered WSS, which may play a role in the development of aortopathy. LEVEL OF EVIDENCE: 3 Technical Efficacy Stage: 3 J. Magn. Reson. Imaging 2020;51:481-491.
BACKGROUND: The effect of different expressions of aortic valve disease on 3D aortic hemodynamics is unclear. PURPOSE: To investigate changes in aortic hemodynamics in patients with dilated ascending aorta (AAo) but different severity of aortic valve stenosis (AS) and/or regurgitation (AR). STUDY TYPE: Retrospective. POPULATION: A total of 111 subjects (86 patients with AAo diameter ≥ 40 mm and 25 healthy controls, all with trileaflet aortic valve [TAV]). Patients were further stratified by TAV dysfunction: n = 9 with combined moderate or severe AS and AR (ASR, 56 ± 13 years), n = 14 with moderate or severe AS (AS, 64 ± 14 years), n = 33 with moderate or severe AR (AR, 62 ± 14 years), n = 30 with neither AS nor AR (no AS/AR, 63 ± 9 years). FIELD STRENGTH/SEQUENCE: 4D flow MRI on 1.5/3T systems for the in vivo analysis of aortic blood flow dynamics. ASSESSMENT: Data analysis included grading of 3D AAo vortex/helix flow and AAo flow eccentricity as well as quantification of systolic peak velocities and wall shear stress (WSS). STATISTICAL TESTS: Continuous variables were compared by one-way analysis of variance or Kruskal-Wallis, followed by a pairwise Tukey or Dunn test if there was a significant difference. RESULTS: All patients demonstrated markedly elevated vortex and helix flow compared with controls (P < 0.05). Peak velocities were significantly elevated in ASR, AS, and ARpatients compared with controls (P < 0.05). Increased flow eccentricity was observed in entire AAo for AR, at the mid and distal AAo for ASR and AS, and at the proximal AAo for no AS/AR. Compared with controls, WSS in the AAo was significantly elevated in ASR and AS patients (P < 0.05) and reduced in no AS/ARpatients (P < 0.05). DATA CONCLUSION: The presence of TAV dysfunction is associated with aberrant hemodynamics and altered WSS, which may play a role in the development of aortopathy. LEVEL OF EVIDENCE: 3 Technical Efficacy Stage: 3 J. Magn. Reson. Imaging 2020;51:481-491.
Authors: Alex Frydrychowicz; Alexander Berger; Alejandro Munoz Del Rio; Maximilian F Russe; Jelena Bock; Andreas Harloff; Michael Markl Journal: Eur Radiol Date: 2011-12-30 Impact factor: 5.315
Authors: Alex J Barker; Michael Markl; Jonas Bürk; Ramona Lorenz; Jelena Bock; Simon Bauer; Jeanette Schulz-Menger; Florian von Knobelsdorff-Brenkenhoff Journal: Circ Cardiovasc Imaging Date: 2012-06-22 Impact factor: 7.792
Authors: Emilie Bollache; Pim van Ooij; Alex Powell; James Carr; Michael Markl; Alex J Barker Journal: Int J Cardiovasc Imaging Date: 2016-07-19 Impact factor: 2.357
Authors: Pim van Ooij; Wouter V Potters; Aart J Nederveen; Bradley D Allen; Jeremy Collins; James Carr; S Chris Malaisrie; Michael Markl; Alex J Barker Journal: Magn Reson Med Date: 2014-04-18 Impact factor: 4.668
Authors: Robert O Bonow; Blase A Carabello; Chatterjee Kanu; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel Journal: Circulation Date: 2006-08-01 Impact factor: 29.690
Authors: Pim van Ooij; Wouter V Potters; Jeremy Collins; Maria Carr; James Carr; S Chris Malaisrie; Paul W M Fedak; Patrick M McCarthy; Michael Markl; Alex J Barker Journal: Ann Biomed Eng Date: 2014-08-14 Impact factor: 3.934
Authors: Joon Bum Kim; Matthew Spotnitz; Mark E Lindsay; Thomas E MacGillivray; Eric M Isselbacher; Thoralf M Sundt Journal: J Am Coll Cardiol Date: 2016-09-13 Impact factor: 24.094
Authors: Michael Markl; Andreas Harloff; Thorsten A Bley; Maxim Zaitsev; Bernd Jung; Ernst Weigang; Mathias Langer; Jürgen Hennig; Alex Frydrychowicz Journal: J Magn Reson Imaging Date: 2007-04 Impact factor: 4.813
Authors: Julio Sotelo; Pamela Franco; Andrea Guala; Lydia Dux-Santoy; Aroa Ruiz-Muñoz; Arturo Evangelista; Hernan Mella; Joaquín Mura; Daniel E Hurtado; José F Rodríguez-Palomares; Sergio Uribe Journal: Front Cardiovasc Med Date: 2022-05-18
Authors: Pim van Ooij; Emile S Farag; Carmen P S Blanken; Aart J Nederveen; Maarten Groenink; R Nils Planken; S Matthijs Boekholdt Journal: J Cardiovasc Magn Reson Date: 2021-02-15 Impact factor: 5.364